ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tyruko 300 mg / 15 ml, Konzentrat zur Herstellung einer Infusionslösung - 
69503001 Sandoz Pharmaceuticals AG
Tyruko 300 mg / 15 ml, Konzentrat zur Herstellung einer Infusionslösung05.11.2024
  05.11.2024
(L04AG03) 
WHO-DDD04.11.2029
01.99. 
01.99. 
B  
Yes 
IP 
1083.67Yes
    
10 %1194.95
  
7680695030013Biotechnologika
  
Composition
natalizumabum 300 mg, natrii chloridum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 51.73 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Natalizumab300mg / 15ml
BAG: Active AgentDose
Natalizumab300 mg
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Sodium Chloride
Polysorbatum 80
 
Source
Data was imported : 07.08.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home